Gastrointestinal permeability following cardiopulmonary bypass.
Bindl
L
L
D002199:Capillary Permeability / Q000187:drug effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects; D004298:Dopamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007413:Intestinal Mucosa / Q000187:drug effects*; D007792:Lactulose / Q000493:pharmacokinetics* / Q000652:urine; D012210:Rhamnose / Q000493:pharmacokinetics* / Q000652:urine; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; C046318:dopexamine; D007792:Lactulose; D012210:Rhamnose; D004298:Dopamine